BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 30959169)

  • 1. P2Y
    Jin H; Ko YS; Park SW; Kim HJ
    Free Radic Biol Med; 2019 May; 136():109-117. PubMed ID: 30959169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P2Y(2)R activation by nucleotides released from oxLDL-treated endothelial cells (ECs) mediates the interaction between ECs and immune cells through RAGE expression and reactive oxygen species production.
    Eun SY; Park SW; Lee JH; Chang KC; Kim HJ
    Free Radic Biol Med; 2014 Apr; 69():157-66. PubMed ID: 24486339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NLRC4, ASC and Caspase-1 Are Inflammasome Components that Are Mediated by P2Y
    Jin H; Kim HJ
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32397236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P2Y2 receptor activation by nucleotides released from highly metastatic breast cancer cells increases tumor growth and invasion via crosstalk with endothelial cells.
    Jin H; Eun SY; Lee JS; Park SW; Lee JH; Chang KC; Kim HJ
    Breast Cancer Res; 2014 Aug; 16(5):R77. PubMed ID: 25156554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P2Y2R-mediated inflammasome activation is involved in tumor progression in breast cancer cells and in radiotherapy-resistant breast cancer.
    Jin H; Ko YS; Kim HJ
    Int J Oncol; 2018 Nov; 53(5):1953-1966. PubMed ID: 30226596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-1β enhances vascular smooth muscle cell proliferation and migration via P2Y2 receptor-mediated RAGE expression and HMGB1 release.
    Eun SY; Ko YS; Park SW; Chang KC; Kim HJ
    Vascul Pharmacol; 2015 Sep; 72():108-17. PubMed ID: 25956731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial Cell-Specific Deletion of P2Y2 Receptor Promotes Plaque Stability in Atherosclerosis-Susceptible ApoE-Null Mice.
    Chen X; Qian S; Hoggatt A; Tang H; Hacker TA; Obukhov AG; Herring PB; Seye CI
    Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):75-83. PubMed ID: 27856454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P2Y
    Thorstenberg ML; Martins MDA; Figliuolo V; Silva CLM; Savio LEB; Coutinho-Silva R
    Mediators Inflamm; 2020; 2020():2545682. PubMed ID: 33061823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial DAMPs and altered mitochondrial dynamics in OxLDL burden in atherosclerosis.
    Khwaja B; Thankam FG; Agrawal DK
    Mol Cell Biochem; 2021 Apr; 476(4):1915-1928. PubMed ID: 33492610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidized Low-Density Lipoprotein Immune Complex Priming of the Nlrp3 Inflammasome Involves TLR and FcγR Cooperation and Is Dependent on CARD9.
    Rhoads JP; Lukens JR; Wilhelm AJ; Moore JL; Mendez-Fernandez Y; Kanneganti TD; Major AS
    J Immunol; 2017 Mar; 198(5):2105-2114. PubMed ID: 28130494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular ATP and Purinergic P2Y
    Schulien I; Hockenjos B; van Marck V; Ayata CK; Follo M; Thimme R; Hasselblatt P
    Cancer Res; 2020 Feb; 80(4):699-708. PubMed ID: 31822494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galectin-3 aggravates ox-LDL-induced endothelial dysfunction through LOX-1 mediated signaling pathway.
    Ou HC; Chou WC; Hung CH; Chu PM; Hsieh PL; Chan SH; Tsai KL
    Environ Toxicol; 2019 Jul; 34(7):825-835. PubMed ID: 30963716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arsenic augments the uptake of oxidized LDL by upregulating the expression of lectin-like oxidized LDL receptor in mouse aortic endothelial cells.
    Hossain E; Ota A; Karnan S; Damdindorj L; Takahashi M; Konishi Y; Konishi H; Hosokawa Y
    Toxicol Appl Pharmacol; 2013 Dec; 273(3):651-8. PubMed ID: 24145059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OxLDL induces vascular endothelial cell pyroptosis through miR-125a-5p/TET2 pathway.
    Zhaolin Z; Jiaojiao C; Peng W; Yami L; Tingting Z; Jun T; Shiyuan W; Jinyan X; Dangheng W; Zhisheng J; Zuo W
    J Cell Physiol; 2019 May; 234(5):7475-7491. PubMed ID: 30370524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rosmarinic acid inhibits oxLDL-induced inflammasome activation under high-glucose conditions through downregulating the p38-FOXO1-TXNIP pathway.
    Nyandwi JB; Ko YS; Jin H; Yun SP; Park SW; Kim HJ
    Biochem Pharmacol; 2020 Dec; 182():114246. PubMed ID: 33011160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of oxidized LDL-induced inflammatory process through NLRP3 inflammasome activation by the deubiquitinating enzyme BRCC36.
    Singh M; Kumari B; Yadav UCS
    Inflamm Res; 2019 Dec; 68(12):999-1010. PubMed ID: 31485755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychological Stress Activates the Inflammasome via Release of Adenosine Triphosphate and Stimulation of the Purinergic Type 2X7 Receptor.
    Iwata M; Ota KT; Li XY; Sakaue F; Li N; Dutheil S; Banasr M; Duric V; Yamanashi T; Kaneko K; Rasmussen K; Glasebrook A; Koester A; Song D; Jones KA; Zorn S; Smagin G; Duman RS
    Biol Psychiatry; 2016 Jul; 80(1):12-22. PubMed ID: 26831917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purinergic P2Y2 Receptor Control of Tissue Factor Transcription in Human Coronary Artery Endothelial Cells: NEW AP-1 TRANSCRIPTION FACTOR SITE AND NEGATIVE REGULATOR.
    Liu Y; Zhang L; Wang C; Roy S; Shen J
    J Biol Chem; 2016 Jan; 291(4):1553-1563. PubMed ID: 26631725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effects of magnolol against oxidized LDL-induced apoptosis in endothelial cells.
    Ou HC; Chou FP; Sheu WH; Hsu SL; Lee WJ
    Arch Toxicol; 2007 Jun; 81(6):421-32. PubMed ID: 17216433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced glycation end products regulate anabolic and catabolic activities via NLRP3-inflammasome activation in human nucleus pulposus cells.
    Song Y; Wang Y; Zhang Y; Geng W; Liu W; Gao Y; Li S; Wang K; Wu X; Kang L; Yang C
    J Cell Mol Med; 2017 Jul; 21(7):1373-1387. PubMed ID: 28224704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.